Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J STAMLER

Showing results (261-270 of 363) with videos related to

Pageof 37
Sort By:
Circulation|October 1, 1979
A self-scoring five-question risk test for coronary heart diseaseA R Dyer, J Stamler, E Ubell, et al.
Circulation|February 1, 1993
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)P R Liebson, G Grandits, R Prineas, et al.
Preventive Medicine|July 1, 1981
The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipidsA W Caggiula, G Christakis, M Farrand, et al.
Circulation|July 1, 1984
Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study GroupW B Kannel, J T Doyle, A M Ostfeld, et al.
Preventive Medicine|May 1, 1988
Serum lipid response to a fat-modified, oatmeal-enhanced dietL Van Horn, L A Emidy, K A Liu, et al.
JAMA|October 6, 1989
Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trialR Stamler, J Stamler, F C Gosch, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1983
Abnormal red blood cell ion transport and hypertension. The People's Gas Company studyM Trevisan, D Ostrow, R Cooper, et al.
Journal of the American College of Cardiology|December 1, 1986
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacinP L Canner, K G Berge, N K Wenger, et al.
The American Journal of Cardiology|May 1, 1986
Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart diseaseR S Crow, P M Rautaharju, R J Prineas, et al.
Circulation Research|September 1, 1989
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factorJ Stamler, M E Mendelsohn, P Amarante, et al.
Pageof 37

Showing results (261-270 of 363) with videos related to

Sort By:
Pageof 37
Circulation|October 1, 1979
A self-scoring five-question risk test for coronary heart diseaseA R Dyer, J Stamler, E Ubell, et al.
Circulation|February 1, 1993
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)P R Liebson, G Grandits, R Prineas, et al.
Preventive Medicine|July 1, 1981
The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipidsA W Caggiula, G Christakis, M Farrand, et al.
Circulation|July 1, 1984
Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study GroupW B Kannel, J T Doyle, A M Ostfeld, et al.
Preventive Medicine|May 1, 1988
Serum lipid response to a fat-modified, oatmeal-enhanced dietL Van Horn, L A Emidy, K A Liu, et al.
JAMA|October 6, 1989
Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trialR Stamler, J Stamler, F C Gosch, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1983
Abnormal red blood cell ion transport and hypertension. The People's Gas Company studyM Trevisan, D Ostrow, R Cooper, et al.
Journal of the American College of Cardiology|December 1, 1986
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacinP L Canner, K G Berge, N K Wenger, et al.
The American Journal of Cardiology|May 1, 1986
Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart diseaseR S Crow, P M Rautaharju, R J Prineas, et al.
Circulation Research|September 1, 1989
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factorJ Stamler, M E Mendelsohn, P Amarante, et al.
Pageof 37